Onesource Specialty Pharma Limited — Others, 30-05-2025: Action(s) taken or orders passed

OneSource Specialty Pharma Limited has announced a board meeting. The company addressed non-compliance related to its Nomination and Remuneration Committee's composition by re-constituting it to include an Independent Director as Chairman. NSE and BSE imposed fines of Rs. 66,000 each for the non-compliance period. The company said these penalties do not materially affect its financial or operational performance but anticipates further fines for the extended non-compliance before complete rectification. This update reflects the company’s efforts to align governance with required standards, protecting stakeholder interests.